Aspect Biosystems Appoints Three New Board Members

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith...READ MORE

$20,000 Wage Subsidy to Make the Bio-Economy More Diverse and Inclusive

The Skilled Newcomer Internships for the Bio-economy is now accepting applicants. Canada’s bio-economy must become more diverse if the industry is to reach the talent needs of the next decade. Today, recent immigrants and internationally educated professionals (IEP) make up 26% of the workforce...READ MORE

adMare Appoints Patricia Gauthier to the Board of Directors

adMare BioInnovations welcomes Patricia Gauthier, President and General Manager of Moderna Canada, as the newest member of its Board of Directors. Patricia brings to adMare a wealth of leadership experience in global pharma and biotech...READ MORE

Evusheld Long-Acting Antibody Combination Approved in the EU for the Treatment of COVID-19

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been approved in the European Union for the treatment of adults and adolescents (aged 12 years and older weighing at least 40 kg) with COVID‑19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID‑19...READ MORE

AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn’s Disease 

AbbVie announced the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of risankizumab (SKYRIZI®, 600 mg intravenous [IV] induction and 360 mg subcutaneous [SC] maintenance therapy) for the treatment of adults with moderately to severely active Crohn’s disease who have had inadequate response, lost response or were intolerant to conventional or biologic therapy...READ MORE

Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis

Aurinia Pharmaceuticals Inc., a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, announced that the European Commission has granted marketing authorization of LUPKYNIS® (voclosporin) to treat adults with active lupus nephritis (LN)…READ MORE

InMed Pharmaceuticals to Report Full Year Fiscal 2022 Financial Results and Business Update on September 23, 2022

InMed Pharmaceuticals Inc., a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on Friday, September 23, 2022 for the fiscal year ended June 30, 2022. To access the call by phone, please go to the registration link, and you will be provided with dial in details...READ MORE

Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union

Pfizer announced positive top-line results from its pivotal E.U. Phase 3 study in infants (NCT04546425) evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD), pneumonia, and acute otitis media caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes contained in the vaccine for the pediatric population...READ MORE

Zucara Therapeutics Positive Proof of Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01

Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that its positive proof-of-concept data has enabled the Company to secure continued funding for a Phase 2 clinical study of ZT-01, which is expected to begin in Q1 2023...READ MORE

Advancing BC’s World-Class Research Talent: Health Research BC Funds 71 Scholars and Research Trainees 

Health Research BC’s funding for 71 researchers through the 2022 Scholar and Research Trainee competitions will help develop, attract and retain BC’s best and brightest health researchers and support the advancement of world-class health research in BC...READ MORE

Province Invests in Research Infrastructure, Innovation at Post-Secondary Institutions

Eight universities in British Columbia have received $30 million to support 120 post-secondary research projects through the BC Knowledge Development Fund. The universities receiving funding include Simon Fraser University, the University of British Columbia, the University of British Columbia-Okanagan, the University of Northern British Columbia, Kwantlen Polytechnic University, Langara College, Vancouver Island University and the University of Victoria...READ MORE

Director, Regulatory Affairs

The Director/Senior Director, Regulatory Affairs is responsible for developing, implementing, and advising on global regulatory strategies for development programs to secure and maintain market access for product(s) in line with business objectives, and in coordination with key internal stakeholders. The incumbent will provide leadership and strategic regulatory oversight for designated projects ensuring that the latest requirements and standards are met. The individual will interface with outside regulatory agencies and business partners in regard to development, regulatory, and registration strategies. The Director/Senior Director of Regulatory Affairs will also provide line management, people development, and performance management as well as support/lead development and implementation of department policies.

LEARN MORE

Technology Licensing Associate, Biologics

AbCellera is a young, energetic, and rapidly growing biotech company with an amazing team that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed into drugs to prevent and treat disease.

We are looking for an experienced Technology Licensing Associate to join our growing Corporate Development team. The successful candidate will support current and emerging R&D activities by reviewing and analyzing intellectual property landscapes, researching licensing terms, and assisting with R&D technology strategy. Our ideal candidate would have a scientific background . As part of a leading and highly innovative company, successful candidates will interface with various teams across the organization including corporate development, R&D, and legal.

LEARN MORE

Lab Technician

The Lab Technician is a key member of the Protein Engineering and Production Team, working closely with the Team Lead Scientist and other Lab Technicians to prepare, carry out, document, analyze and report on investigational research experiments.

General responsibilities include: Plans, performs and analyzes experiments under supervision using proper cell biology, biochemical and molecular techniques, handles primary cells (T-cells, NK cells, PBMCs, etc.) in a biosafety cabinet using proper aseptic techniques,

performs flow cytometry with large number of samples, and multiple antibodies staining.

Produces proteins using mammalian and bacterial cells, and purifies proteins using column chromatography.

LEARN MORE

Omega Laboratories is the global leader in speciality testing for drugs of abuse, antigen, antibody, and PCR laboratory-based molecular tests, including Covid19. We provide exceptional software solutions for clinical and forensic operations, with record turn around times without compromise on quality. We serve 

the unique needs and demands of programs and organizations around the globe.

Visit Website

Sernova is a regenerative medicine company developing therapeutic technologies with multibillion-dollar market potential for each of its clinical indications.Cell Pouch™, combined with its immune protection technology, offers therapeutic cells local protection from immune system attack creating an effective, safe, long-term and convenient therapeutic option for patients with chronic disease who seek to improve their quality of life.

Visit Website